#Retatrutide,
An experimental GLP-1 drug pushes the limits of weight loss.
There are risks.
Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity to shed, on average, 28 percent of their body weight
— a substantial step up in potency from the existing crop of GLP-1 medicines.
But that breakthrough also is prompting some doctors to urge caution.
In interviews, doctors warned that using a drug to shrink your body that much will require close medical management
And — much more than the level of monitoring many people are now getting when taking drugs like Ozempic, Wegovy and Zepbound.
https://www.washingtonpost.com/health/2026/05/29/when-is-glp-1-drug-too-potent/






